1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €12.07 (+280.76%). The median is €6.90 (+117.67%).
| Buy |
7 |
| Hold |
3 |
| Sell |
1 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 27.72M | 3.99% |
| Gross profit | 11.64M | 15.59% |
| Net profit | -15.76M | 0.17% |
| EBITDA | -11.3M | 3.51% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €58.18M |
Number of shares | 18.54M |
52-week high/low | €13.93 - €2.59 |
| Dividends | No |
Beta | 1.92 |
P/E ratio | -0.89 |
PEG ratio | 0.00 |
P/B ratio | 0.70 |
P/S ratio | 0.57 |
Company profile
| Name | Outsed Medical |
| CEO | Leslie L. Trigg |
| Headquarters | San Jose,
ca USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Employees | 310 |
Discover assets
Shareholders of Outsed Medical also invest in the following assets
